Kiniksa Pharmaceuticals
KNSA
KNSA
131 hedge funds and large institutions have $659M invested in Kiniksa Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 42 closing their positions.
Holders
131
Holders Change
-23
Holders Change %
-14.94%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
53
Reduced
45
Closed
42
Calls
$1.34M
Puts
$1.25M
Net Calls
+$93K
Net Calls Change
-$1.2M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$37.1M |
| 2 |
B
2
Braidwell
Stamford,
Connecticut
|
$38.4M |
| 3 |
3
BlackRock
New York
|
$85.7M |
| 4 |
4
Millennium Management
New York
|
$11.6M |
| 5 |
RCMNY
5
Rubric Capital Management (New York)
New York
|
$45.2M |
